| Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA SC Johnston, JD Easton, M Farrant, W Barsan, RA Conwit, JJ Elm, ... New England Journal of Medicine 379 (3), 215-225, 2018 | 995 | 2018 |
| Evolution of the modified Rankin scale and its use in future stroke trials JP Broderick, O Adeoye, J Elm Stroke 48 (7), 2007-2012, 2017 | 636 | 2017 |
| Randomized trial of three anticonvulsant medications for status epilepticus J Kapur, J Elm, JM Chamberlain, W Barsan, J Cloyd, D Lowenstein, ... New England Journal of Medicine 381 (22), 2103-2113, 2019 | 446 | 2019 |
| The impact of depressive symptoms in early Parkinson disease B Ravina, R Camicioli, PG Como, L Marsh, J Jankovic, D Weintraub, ... Neurology 69 (4), 342-347, 2007 | 399 | 2007 |
| Neurological Emergencies Treatment Trials Network, and the POINT Investigators. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA SC Johnston, JD Easton, M Farrant, W Barsan, RA Conwit, JJ Elm, ... N Engl J Med 379 (3), 215-225, 2018 | 241 | 2018 |
| Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial KN Sheth, JJ Elm, BJ Molyneaux, H Hinson, LA Beslow, GK Sze, ... The Lancet Neurology 15 (11), 1160-1169, 2016 | 215 | 2016 |
| Outcomes associated with clopidogrel-aspirin use in minor stroke or transient ischemic attack: a pooled analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling … Y Pan, JJ Elm, H Li, JD Easton, Y Wang, M Farrant, X Meng, AS Kim, ... JAMA neurology 76 (12), 1466-1473, 2019 | 190 | 2019 |
| Transcranial direct current stimulation vs sham stimulation to treat aphasia after stroke: a randomized clinical trial J Fridriksson, C Rorden, J Elm, S Sen, MS George, L Bonilha JAMA neurology 75 (12), 1470-1476, 2018 | 181 | 2018 |
| Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial JM Chamberlain, J Kapur, S Shinnar, J Elm, M Holsti, L Babcock, ... The Lancet 395 (10231), 1217-1224, 2020 | 174 | 2020 |
| Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial K Kieburtz, BC Tilley, JJ Elm, D Babcock, R Hauser, GW Ross, ... Jama 313 (6), 584-593, 2015 | 171 | 2015 |
| Adopting a patient-centered approach to primary outcome analysis of acute stroke trials using a utility-weighted modified Rankin scale N Chaisinanunkul, O Adeoye, RJ Lewis, JC Grotta, J Broderick, TG Jovin, ... Stroke 46 (8), 2238-2243, 2015 | 163 | 2015 |
| Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design SC Johnston, JD Easton, M Farrant, W Barsan, H Battenhouse, R Conwit, ... International Journal of Stroke 8 (6), 479-483, 2013 | 163 | 2013 |
| Oral anticoagulation and functional outcome after intracerebral hemorrhage A Biffi, JB Kuramatsu, A Leasure, H Kamel, C Kourkoulis, K Schwab, ... Annals of neurology 82 (5), 755-765, 2017 | 147 | 2017 |
| Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial L Neurol Lancet Neurol 14 (8), 795-803, 2015 | 128 | 2015 |
| The established status epilepticus trial 2013 T Bleck, H Cock, J Chamberlain, J Cloyd, J Connor, J Elm, N Fountain, ... Epilepsia 54, 89-92, 2013 | 128 | 2013 |
| Fall frequency and risk assessment in early Parkinson's disease TS Voss, JJ Elm, CL Wielinski, MJ Aminoff, D Bandyopadhyay, KL Chou, ... Parkinsonism & related disorders 18 (7), 837-841, 2012 | 110 | 2012 |
| Pilot study of intravenous glyburide in patients with a large ischemic stroke KN Sheth, WT Kimberly, JJ Elm, TA Kent, P Mandava, AJ Yoo, G Thomalla, ... Stroke 45 (1), 281-283, 2014 | 91 | 2014 |
| Glyburide is associated with attenuated vasogenic edema in stroke patients WT Kimberly, TWK Battey, L Pham, O Wu, AJ Yoo, KL Furie, AB Singhal, ... Neurocritical care 20, 193-201, 2014 | 89 | 2014 |
| Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs BC Tilley, YY Palesch, K Kieburtz, B Ravina, P Huang, JJ Elm, K Shannon, ... Neurology 66 (5), 628-633, 2006 | 87 | 2006 |
| Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus JT Connor, JJ Elm, KR Broglio, Esett and Adapt-It Investigators Journal of clinical epidemiology 66 (8), S130-S137, 2013 | 85 | 2013 |
